JP2008508352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508352A5 JP2008508352A5 JP2007524767A JP2007524767A JP2008508352A5 JP 2008508352 A5 JP2008508352 A5 JP 2008508352A5 JP 2007524767 A JP2007524767 A JP 2007524767A JP 2007524767 A JP2007524767 A JP 2007524767A JP 2008508352 A5 JP2008508352 A5 JP 2008508352A5
- Authority
- JP
- Japan
- Prior art keywords
- benzo
- dihydro
- phenyl
- indol
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 claims description 9
- -1 methoxy, hydroxy Chemical group 0.000 claims 116
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 150000002431 hydrogen Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000003277 amino group Chemical group 0.000 claims 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 3
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 claims 3
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 3
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 claims 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 claims 3
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 claims 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 2
- 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 claims 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000005956 isoquinolyl group Chemical group 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000005493 quinolyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- QRCGFTXRXYMJOS-UHFFFAOYSA-N 4h-1,4-benzoxazin-3-one Chemical compound C1=CC=C2NC(=O)COC2=C1 QRCGFTXRXYMJOS-UHFFFAOYSA-N 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 0 O=C(NCCCN1CCCCC1)N1CCN(Cc2c(CCN=*3)c3ccc2)CC1 Chemical compound O=C(NCCCN1CCCCC1)N1CCN(Cc2c(CCN=*3)c3ccc2)CC1 0.000 description 13
- KPWHQJNIRXSRBQ-UHFFFAOYSA-N CC(CN(CC1)C(NCCCN2CCCCC2)=O)N1c1cccc(C)c1 Chemical compound CC(CN(CC1)C(NCCCN2CCCCC2)=O)N1c1cccc(C)c1 KPWHQJNIRXSRBQ-UHFFFAOYSA-N 0.000 description 1
- BLVXFNBKHSONDD-UHFFFAOYSA-N Cc1cc(N(CC2)CCN2C(NCCCN2CCCCC2)=O)ccc1 Chemical compound Cc1cc(N(CC2)CCN2C(NCCCN2CCCCC2)=O)ccc1 BLVXFNBKHSONDD-UHFFFAOYSA-N 0.000 description 1
- MHFWLJDIZUQWSE-UHFFFAOYSA-N Cc1ccccc1N(CC1)CCN1C(NCCCN1CCCCC1)=O Chemical compound Cc1ccccc1N(CC1)CCN1C(NCCCN1CCCCC1)=O MHFWLJDIZUQWSE-UHFFFAOYSA-N 0.000 description 1
- DMAORECRYRHUBR-UHFFFAOYSA-N O=C(NCCCN1CCCCC1)N(CC1)CCN1C1c2ccccc2CCC1 Chemical compound O=C(NCCCN1CCCCC1)N(CC1)CCN1C1c2ccccc2CCC1 DMAORECRYRHUBR-UHFFFAOYSA-N 0.000 description 1
- VHORVPIINKLKEU-UHFFFAOYSA-N O=C(NCCCN1CCCCC1)N(CC1)CCN1S(c(cc1)ccc1F)(=O)=O Chemical compound O=C(NCCCN1CCCCC1)N(CC1)CCN1S(c(cc1)ccc1F)(=O)=O VHORVPIINKLKEU-UHFFFAOYSA-N 0.000 description 1
- DITLHGOUPJXJJL-UHFFFAOYSA-N O=C(NCCCN1CCCCC1)N(CC1)CCN1c1ccccc1S Chemical compound O=C(NCCCN1CCCCC1)N(CC1)CCN1c1ccccc1S DITLHGOUPJXJJL-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401970A SE0401970D0 (sv) | 2004-08-02 | 2004-08-02 | Novel compounds |
| PCT/SE2005/001188 WO2006014135A1 (en) | 2004-08-02 | 2005-07-27 | Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508352A JP2008508352A (ja) | 2008-03-21 |
| JP2008508352A5 true JP2008508352A5 (enExample) | 2009-03-12 |
Family
ID=32906882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007524767A Abandoned JP2008508352A (ja) | 2004-08-02 | 2005-07-27 | うつ病の治療のためのヒスタミンｈ３受容体リガンドとしての新規なピペリジン誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070249618A1 (enExample) |
| EP (1) | EP1784394A1 (enExample) |
| JP (1) | JP2008508352A (enExample) |
| KR (1) | KR20070039118A (enExample) |
| CN (1) | CN1993340A (enExample) |
| AU (1) | AU2005267931A1 (enExample) |
| BR (1) | BRPI0514032A (enExample) |
| CA (1) | CA2576109A1 (enExample) |
| IL (1) | IL180547A0 (enExample) |
| MX (1) | MX2007001227A (enExample) |
| NO (1) | NO20071140L (enExample) |
| RU (1) | RU2007106969A (enExample) |
| SE (1) | SE0401970D0 (enExample) |
| WO (1) | WO2006014135A1 (enExample) |
| ZA (1) | ZA200700679B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1753512T3 (pl) | 2004-05-28 | 2009-03-31 | 4Sc Ag | Tetrahydropirydotiofeny |
| WO2005120642A2 (en) | 2004-06-11 | 2005-12-22 | Altana Pharma Ag | Tetrahydropyridothiophenes for treating hyperproliferative disorders |
| EP1795527B1 (en) * | 2004-09-07 | 2009-04-22 | Banyu Pharmaceutical Co., Ltd. | Carbamoyl-substituted spiro derivative |
| WO2006028161A1 (ja) * | 2004-09-09 | 2006-03-16 | Research Foundation Itsuu Laboratory | セロトニン５－ｈｔ３受容体作動薬 |
| GB0611907D0 (en) | 2006-06-15 | 2006-07-26 | Glaxo Group Ltd | Compounds |
| CA2596202A1 (en) | 2005-02-09 | 2006-08-17 | Altana Pharma Ag | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer |
| US7741488B2 (en) | 2005-02-11 | 2010-06-22 | 4Sc Ag | Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer |
| US7763728B2 (en) | 2005-05-25 | 2010-07-27 | 4Sc Ag | Tetrahydropyridothiophenes |
| US7714136B2 (en) | 2005-05-25 | 2010-05-11 | 4Sc Ag | Tetrahydropyridothiophenes |
| AU2006275568A1 (en) | 2005-08-02 | 2007-02-08 | Neurogen Corporation | Dipiperazinyl ketones and related analogues |
| AU2007219509A1 (en) * | 2006-01-18 | 2007-09-07 | Siena Biotech S.P.A | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| US7514433B2 (en) * | 2006-08-03 | 2009-04-07 | Hoffmann-La Roche Inc. | 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| TW200918062A (en) | 2007-09-12 | 2009-05-01 | Wyeth Corp | Azacyclylisoquinolinone and-isoindolinone derivatives as histamine-3 antagonists |
| EP2318388A2 (en) * | 2008-07-23 | 2011-05-11 | Schering Corporation | Tricyclic spirocycle derivatives and methods of use thereof |
| PT3252057T (pt) | 2009-12-04 | 2024-06-04 | Sunovion Pharmaceuticals Inc | Compostos multicíclicos e métodos de utilização dos mesmos |
| DE102011083283A1 (de) * | 2011-09-23 | 2013-03-28 | Beiersdorf Ag | Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen |
| MX2019000982A (es) | 2016-07-29 | 2019-07-04 | Sunovion Pharmaceuticals Inc | Compuestos y composiciones y usos de los mismos. |
| EA201990400A1 (ru) | 2016-07-29 | 2019-07-31 | Суновион Фармасьютикалз, Инк. | Соединения и композиции и их применение |
| CN116808023A (zh) | 2017-02-16 | 2023-09-29 | 桑诺维恩药品公司 | 治疗精神分裂症的方法 |
| JP7191085B2 (ja) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | イソクロマン化合物およびその使用 |
| MX2020008537A (es) | 2018-02-16 | 2021-01-08 | Sunovion Pharmaceuticals Inc | Sales, formas cristalinas y metodos de produccion de las mismas. |
| US10689360B1 (en) * | 2019-01-30 | 2020-06-23 | Insilico Medicine Ip Limited | TLR inhibitors |
| CN113784755B (zh) | 2019-03-14 | 2024-05-10 | 赛诺维信制药公司 | 异色满基化合物的盐及其结晶形式、制备方法、治疗用途和药物组合物 |
| CA3180115A1 (en) | 2020-04-14 | 2021-10-21 | Sunovion Pharmaceuticals Inc. | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders |
| CN114685401A (zh) * | 2020-12-28 | 2022-07-01 | 江苏天士力帝益药业有限公司 | 一种二（4-甲基哌嗪-1-基）甲酮的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1183784B (de) * | 1963-05-16 | 1964-12-17 | Fuji Photo Film Co Ltd | Verfahren zur Empfindlichkeitssteigerung und Beschleunigung der Entwicklung von Halogensilberemulsionen in Photomaterialien |
| FR1589754A (enExample) * | 1968-10-17 | 1970-04-06 | ||
| JPS58169143A (ja) * | 1982-03-31 | 1983-10-05 | Fuji Photo Film Co Ltd | 重合画像形成方法 |
| CA2309319A1 (en) * | 1997-11-10 | 1999-05-20 | Bristol-Myers Squibb Company | Benzothiazole protein tyrosine kinase inhibitors |
| NZ522928A (en) * | 2000-06-21 | 2005-05-27 | F | Benzothiazole derivatives |
-
2004
- 2004-08-02 SE SE0401970A patent/SE0401970D0/xx unknown
-
2005
- 2005-07-27 US US11/572,966 patent/US20070249618A1/en not_active Abandoned
- 2005-07-27 KR KR1020077002642A patent/KR20070039118A/ko not_active Withdrawn
- 2005-07-27 MX MX2007001227A patent/MX2007001227A/es not_active Application Discontinuation
- 2005-07-27 CA CA002576109A patent/CA2576109A1/en not_active Abandoned
- 2005-07-27 CN CNA2005800262338A patent/CN1993340A/zh active Pending
- 2005-07-27 AU AU2005267931A patent/AU2005267931A1/en not_active Abandoned
- 2005-07-27 EP EP05766829A patent/EP1784394A1/en not_active Withdrawn
- 2005-07-27 WO PCT/SE2005/001188 patent/WO2006014135A1/en not_active Ceased
- 2005-07-27 RU RU2007106969/04A patent/RU2007106969A/ru unknown
- 2005-07-27 JP JP2007524767A patent/JP2008508352A/ja not_active Abandoned
- 2005-07-27 BR BRPI0514032-3A patent/BRPI0514032A/pt not_active Application Discontinuation
-
2007
- 2007-01-04 IL IL180547A patent/IL180547A0/en unknown
- 2007-01-24 ZA ZA200700679A patent/ZA200700679B/xx unknown
- 2007-02-28 NO NO20071140A patent/NO20071140L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007105970A (ru) | Пиперидиновые производные в качестве лигандов гистаминового из рецептора | |
| RU2007106969A (ru) | Новые пиперидиновые производные в качестве лигандов гистаминового рецептора для лечения депрессии | |
| JP2008508353A5 (enExample) | ||
| RU2007105968A (ru) | Новые пиперидиновые производные для лечения депрессии | |
| US6924302B2 (en) | Substituted triazole diamine derivatives as kinase inhibitors | |
| CN101952254B (zh) | Atp结合盒转运蛋白的异喹啉调节剂 | |
| JP4092203B2 (ja) | 新規のシクロオキシゲナーゼ２選択的阻害剤としての置換アリール化合物、組成物、および使用方法 | |
| KR20080097456A (ko) | 소화관 궤양의 치료제 또는 예방제 | |
| CN113396145A (zh) | Pfkfb3抑制剂及其用途 | |
| WO2001056607A1 (en) | Integrin expression inhibitors | |
| JP2005529089A5 (enExample) | ||
| JPWO2001056607A1 (ja) | インテグリン発現阻害剤 | |
| WO2010114881A1 (en) | Anti-neoplastic compounds, compositions and methods | |
| JP2005507918A5 (enExample) | ||
| BRPI0823228B1 (pt) | moduladores de cassete de ligação a atp | |
| RU2002133863A (ru) | Производные замещенного пирролопиридинона, пригодные в качестве ингибиторов фосфодиэстеразы | |
| CN101460476A (zh) | 有机化合物 | |
| JP2012524111A5 (enExample) | ||
| RU2005136368A (ru) | Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний | |
| NZ500252A (en) | 6-(4-Methyl-piperazin-1-yl)-1H-indole derivatives useful as 5HT1A, 5HT1B and 5HT1D receptor antagonists | |
| CN106573908A (zh) | 羧酸化合物及其制备方法和用途 | |
| RU2006123418A (ru) | Новые антагонисты м3 мускаринового ацетилхолинового рецептора | |
| JP2008524249A5 (enExample) | ||
| CA2547591A1 (en) | Novel compounds and compositions as cathepsin inhibitors | |
| JP2004525184A5 (enExample) |